Tower Research Capital LLC (TRC)

Position in SLN — Silence Therapeutics plc

CIK 1533421 NEW YORK, NY

Position in SLN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$17,996

+$5,807 QoQ

Shares Held

1,639

-29.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#64

of 72 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. SLN ranks #258 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	4,547	$4,218,570
2	BBIO	BridgeBio Pharma, Inc.	38,206	$2,845,582
3	ARWR	Arrowhead Pharmaceuticals, Inc.	34,537	$2,815,110
4	VRTX	Vertex Pharmaceuticals Inc / Ma	4,292	$2,131,964
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,927	$2,108,602
6	AXSM	Axsome Therapeutics, Inc.	6,437	$1,575,584
7	INSM	INSMED Inc	10,927	$1,165,036
8	ROIV	Roivant Sciences Ltd.	32,746	$1,158,880

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,996	1,639	-29.1%	Shares	Defined	2026-08-11
2026-03-31	$12,189	2,313	-5.5%	Shares	Defined	2026-05-15
2025-12-31	$14,883	2,448	+0.0%	Shares	Defined	2026-02-17
2025-09-30	$12,699	2,447	+0.8%	Shares	Defined	2025-11-14
2025-06-30	$14,082	2,428	+2.6%	Shares	Defined	2025-08-15
2025-03-31	$6,674	2,367	+274.5%	Shares	Defined	2025-05-15
2024-12-31	$4,348	632	-10.6%	Shares	Defined	2025-02-13
2023-12-31	$12,280	707	-11.6%	Shares	Other	2024-02-13
2023-06-30	$4,400	800	+566.7%	Shares	Other	2023-08-14
2022-06-30	$1,422	120	+2.6%	Shares	Other	2022-08-15
2022-03-31	$2,223	117	—	Shares	Other	2022-05-12
No filing history on record for this holder in this stock.